Research map: Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33/ST2 signaling

Back to the article

Papers in this map

  1. Accurate structure prediction of biomolecular interactions with AlphaFold 3 · Josh Abramson · 2024 · 16046 citations · Cited by this paper
  2. Secreted SULF1 protein modulates CD8 + T cell exhaustion by promoting TAM polarization in gastric cancer · 2026 · Related
  3. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features · Wolfgang Kabsch · 1983 · 15901 citations · Cited by this paper
  4. Immunoglobulin gene polymorphisms shape the naïve B-cell receptor repertoire; relevance to celiac disease · 2026 · Related
  5. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions · Eugene Krissinel · 2004 · 3882 citations · Cited by this paper
  6. Inhibition of cGAS in dendritic cells suppresses maturation and prolongs allograft survival in mice · 2026 · Related
  7. A Large-Scale, Consortium-Based Genomewide Association Study of Asthma · Miriam F. Moffatt · 2010 · 2071 citations · Cited by this paper
  8. RASSF2 promoter hypermethylation determines malignant and microenvironmental features in lung cancer · 2026 · Related
  9. Interleukin-33 in health and disease · Foo Yew Liew · 2016 · 1181 citations · Cited by this paper
  10. Radiotherapy combined with anti-PD-1 immunotherapy promotes ferroptosis-driven control of hepatocellular carcinoma · 2025 · Related
  11. A series of PDB-related databanks for everyday needs · Wouter G. Touw · 2014 · 1029 citations · Cited by this paper
  12. Structures of clinical antibodies bound to IL-33 uncover two distinct epitopes underlying differential efficacy · 2026 · Related
  13. The CCP 4 suite: integrative software for macromolecular crystallography · Jon Agirre · 2023 · 948 citations · Cited by this paper
  14. The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients · 2026 · Related
  15. Interleukin‐33 ( IL ‐33): A nuclear cytokine from the IL ‐1 family · Corinne Cayrol · 2017 · 902 citations · Cited by this paper
  16. A transcriptional signature of resting mast cells is associated with improved disease outcome in HR+HER2- breast cancer · 2026 · Related
  17. IL-33 is a crucial amplifier of innate rather than acquired immunity · Keisuke Oboki · 2010 · 661 citations · Cited by this paper
  18. IRF3 in viral infections: more than just triggering the interferon response · 2025 · Related
  19. IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs · Kathleen R. Bartemes · 2011 · 556 citations · Cited by this paper
  20. Regulatory mechanisms of ALKBH5/CIITA axis in the synergistic modulation of hepatocellular carcinoma radiotherapy and immunotherapy · 2026 · Related
  21. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma · Michael E. Wechsler · 2021 · 427 citations · Cited by this paper
  22. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells · Emma Lefrançais · 2014 · 397 citations · Cited by this paper
  23. Can AlphaFold2 predict the impact of missense mutations on structure? · Gwen R. Buel · 2022 · 354 citations · Cited by this paper
  24. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine · Corinne Cayrol · 2022 · 332 citations · Cited by this paper
  25. Using AlphaFold to predict the impact of single mutations on protein stability and function · Marina A. Pak · 2023 · 301 citations · Cited by this paper
  26. DDMut: predicting effects of mutations on protein stability using deep learning · Yunzhuo Zhou · 2023 · 281 citations · Cited by this paper
  27. Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations · Robert J. Snelgrove · 2014 · 262 citations · Cited by this paper
  28. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial · Klaus Friedrich Rabe · 2021 · 230 citations · Cited by this paper
  29. Structural insights into the interaction of IL-33 with its receptors · Xi Liu · 2013 · 223 citations · Cited by this paper
  30. Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling Complexes · Andreas Lingel · 2009 · 220 citations · Cited by this paper
  31. Lung megakaryocytes are immune modulatory cells · Daphne N. Pariser · 2020 · 185 citations · Cited by this paper
  32. Measuring Protein‐Protein and Protein‐Nucleic Acid Interactions by Biolayer Interferometry · Azmiri Sultana · 2015 · 151 citations · Cited by this paper
  33. A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma · Dirk E. Smith · 2017 · 150 citations · Cited by this paper
  34. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling · Jennifer E. Ho · 2013 · 126 citations · Cited by this paper
  35. Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans · Hao Wu · 2009 · 105 citations · Cited by this paper
  36. Oxidised IL-33 drives COPD epithelial pathogenesisviaST2-independent RAGE/EGFR signalling complex · Sam Strickson · 2023 · 97 citations · Cited by this paper
  37. Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease · Anna Latiano · 2013 · 96 citations · Cited by this paper
  38. Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans · Nicole Mende · 2022 · 73 citations · Cited by this paper
  39. IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor · Sebastian Günther · 2017 · 72 citations · Cited by this paper

Source: OpenAlex (CC0)